Related Experiment Video
Updated: Jul 2, 2026
05:06
Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy
Published on: July 14, 2023
[Neuropathy and type 1 diabetes mellitus]
Ewa Otto-Buczkowska1, Zofia Kazibutowska, Jacek Sołtyk
1Upper Silesia Child Health Centre, Katowice, Poland. em.buczkowski@pro.onet.pl
Pediatric Endocrinology, Diabetes, and Metabolism
|August 30, 2008
Summary
Diabetic neuropathy, a common diabetes complication, affects both type 1 and type 2 patients. Autonomic neuropathy is a serious risk marker for mortality and influences microcirculation, potentially leading to other diabetic complications.
Area of Science:
- Neurology
- Endocrinology
- Diabetology
Background:
- Diabetic neuropathy is the most prevalent neuropathy type, impacting both type 1 and type 2 diabetes patients.
- Manifestations are more severe and progress faster in type 1 diabetes.
- Peripheral and autonomic neuropathy serve as significant risk markers for mortality.
Purpose of the Study:
- To explore the clinical aspects and unanswered questions surrounding diabetic neuropathy.
- To highlight the significance of diabetic autonomic neuropathy (DAN) as a complication.
- To understand the influence of DAN on microcirculation and late diabetic complications.
Main Methods:
- Review of existing literature on diabetic neuropathy.
- Analysis of clinical manifestations and risk factors.
- Investigation into the relationship between DAN and microcirculation.
Main Results:
- Diabetic neuropathy affects both type 1 and type 2 diabetes, with greater severity in type 1.
- Diabetic autonomic neuropathy is a serious complication, often preceding other diabetic issues.
- DAN significantly impacts microcirculation, increasing the risk of other diabetic complications.
Conclusions:
- Diabetic neuropathy requires further research to address remaining questions.
- Diabetic autonomic neuropathy is a critical complication with significant mortality risk.
- Understanding DAN's impact on microcirculation is key to managing late diabetic complications.
Related Concept Videos
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.